Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Themistoklis Zisis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemistry|September 9, 2015
Interfacial Activation of Candida antarctica Lipase B: Combined Evidence from Experiment and SimulationThemistoklis Zisis, Lydia Freddolino, Petri Turunen, et al.
Bioconjugate Chemistry|August 29, 2017
Affinity-Based Purification of Polyisocyanopeptide BioconjugatesRoel Hammink, Loek J Eggermont, Themistoklis Zisis, et al.
Biophysical Journal|December 10, 2021
Disentangling cadherin-mediated cell-cell interactions in collective cancer cell migrationThemistoklis Zisis, David B Brückner, Tom Brandstätter, et al.
ACS Applied Materials & Interfaces|July 20, 2021
Sequential and Switchable Patterning for Studying Cellular Processes under Spatiotemporal ControlThemistoklis Zisis, Jan Schwarz, Miriam Balles, et al.
Haematologica|October 13, 2018
Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostaticsFabian Koczian, Olga Nagło, Jan Vomacka, et al.
Cellular and Molecular Life Sciences : CMLS|September 13, 2018
Transcriptional effects of actin-binding compounds: the cytoplasm sets the toneFlorian A Gegenfurtner, Themistoklis Zisis, Nader Al Danaf, et al.
Angewandte Chemie (International Ed. in English)|July 26, 2021
Tetrapyrrolic Pigments from Heme- and Chlorophyll Breakdown are Actin-Targeting CompoundsCornelia A Karg, Shuaijun Wang, Nader Al Danaf, et al.
Cell Death & Disease|April 5, 2019
Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapyLisa Pfitzer, Christina Moser, Florian Gegenfurtner, et al.
Cell Chemical Biology|February 24, 2021
Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growthMartin Müller, Susanne Gerndt, Yu-Kai Chao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemistry|September 9, 2015
Interfacial Activation of Candida antarctica Lipase B: Combined Evidence from Experiment and SimulationThemistoklis Zisis, Lydia Freddolino, Petri Turunen, et al.
Bioconjugate Chemistry|August 29, 2017
Affinity-Based Purification of Polyisocyanopeptide BioconjugatesRoel Hammink, Loek J Eggermont, Themistoklis Zisis, et al.
Biophysical Journal|December 10, 2021
Disentangling cadherin-mediated cell-cell interactions in collective cancer cell migrationThemistoklis Zisis, David B Brückner, Tom Brandstätter, et al.
ACS Applied Materials & Interfaces|July 20, 2021
Sequential and Switchable Patterning for Studying Cellular Processes under Spatiotemporal ControlThemistoklis Zisis, Jan Schwarz, Miriam Balles, et al.
Haematologica|October 13, 2018
Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostaticsFabian Koczian, Olga Nagło, Jan Vomacka, et al.
Cellular and Molecular Life Sciences : CMLS|September 13, 2018
Transcriptional effects of actin-binding compounds: the cytoplasm sets the toneFlorian A Gegenfurtner, Themistoklis Zisis, Nader Al Danaf, et al.
Angewandte Chemie (International Ed. in English)|July 26, 2021
Tetrapyrrolic Pigments from Heme- and Chlorophyll Breakdown are Actin-Targeting CompoundsCornelia A Karg, Shuaijun Wang, Nader Al Danaf, et al.
Cell Death & Disease|April 5, 2019
Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapyLisa Pfitzer, Christina Moser, Florian Gegenfurtner, et al.
Cell Chemical Biology|February 24, 2021
Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growthMartin Müller, Susanne Gerndt, Yu-Kai Chao, et al.
Pageof 1